RE:Nobody wants to get rich slowSo far, the market has given no valuation to the potential revenue Ceapro could generate from its many products under development. At this point in time, there is no guarantee that any of these products will generate significant future revenues.
And the reason for no valuation is simple, the investment commnuity as a whole has zero confidence in the CZO management, hence the low volumes.